Cargando…
Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer
Although circulating cell-free DNA (cfDNA) is a promising biomarker for the diagnosis and prognosis of various tumors, clinical correlation of cfDNA with gastric cancer has not been fully understood. To address this, we developed a highly sensitive cfDNA capture system by integrating polydopamine (P...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710035/ https://www.ncbi.nlm.nih.gov/pubmed/33264292 http://dx.doi.org/10.1371/journal.pone.0242145 |
_version_ | 1783617864382545920 |
---|---|
author | Bu, Jiyoon Lee, Tae Hee Jeong, Woo-jin Poellmann, Michael J. Mudd, Kara Eun, Hyuk Soo Liu, Elizabeth W. Hong, Seungpyo Hyun, Sung Hee |
author_facet | Bu, Jiyoon Lee, Tae Hee Jeong, Woo-jin Poellmann, Michael J. Mudd, Kara Eun, Hyuk Soo Liu, Elizabeth W. Hong, Seungpyo Hyun, Sung Hee |
author_sort | Bu, Jiyoon |
collection | PubMed |
description | Although circulating cell-free DNA (cfDNA) is a promising biomarker for the diagnosis and prognosis of various tumors, clinical correlation of cfDNA with gastric cancer has not been fully understood. To address this, we developed a highly sensitive cfDNA capture system by integrating polydopamine (PDA) and silica. PDA-silica hybrids incorporated different molecular interactions to a single system, enhancing cfDNA capture by 1.34-fold compared to the conventional silica-based approach (p = 0.001), which was confirmed using cell culture supernatants. A clinical study using human plasma samples revealed that the diagnostic accuracy of the new system to be superior than the commercially available cfDNA kit, as well as other serum antigen tests. Among the cancer patients, plasma cfDNA levels exhibited a good correlation with the size of a tumor. cfDNA was also predicative of distant metastasis, as the median cfDNA levels of metastatic cancer patients were ~60-fold higher than those without metastasis (p = 0.008). Furthermore, high concordance between tissue biopsy and cfDNA genomic analysis was found, as HER2 expression in cfDNA demonstrated an area under ROC curve (AUC) of 0.976 (p <0.001) for detecting patients with HER2-positive tumors. The new system also revealed high prognostic capability of cfDNA, as the concentration of cfDNA was highly associated with the survival outcomes. Our novel technology demonstrates the potential to achieve efficient detection of cfDNA that may serve as a reliable biomarker for gastric tumor. |
format | Online Article Text |
id | pubmed-7710035 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-77100352020-12-03 Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer Bu, Jiyoon Lee, Tae Hee Jeong, Woo-jin Poellmann, Michael J. Mudd, Kara Eun, Hyuk Soo Liu, Elizabeth W. Hong, Seungpyo Hyun, Sung Hee PLoS One Research Article Although circulating cell-free DNA (cfDNA) is a promising biomarker for the diagnosis and prognosis of various tumors, clinical correlation of cfDNA with gastric cancer has not been fully understood. To address this, we developed a highly sensitive cfDNA capture system by integrating polydopamine (PDA) and silica. PDA-silica hybrids incorporated different molecular interactions to a single system, enhancing cfDNA capture by 1.34-fold compared to the conventional silica-based approach (p = 0.001), which was confirmed using cell culture supernatants. A clinical study using human plasma samples revealed that the diagnostic accuracy of the new system to be superior than the commercially available cfDNA kit, as well as other serum antigen tests. Among the cancer patients, plasma cfDNA levels exhibited a good correlation with the size of a tumor. cfDNA was also predicative of distant metastasis, as the median cfDNA levels of metastatic cancer patients were ~60-fold higher than those without metastasis (p = 0.008). Furthermore, high concordance between tissue biopsy and cfDNA genomic analysis was found, as HER2 expression in cfDNA demonstrated an area under ROC curve (AUC) of 0.976 (p <0.001) for detecting patients with HER2-positive tumors. The new system also revealed high prognostic capability of cfDNA, as the concentration of cfDNA was highly associated with the survival outcomes. Our novel technology demonstrates the potential to achieve efficient detection of cfDNA that may serve as a reliable biomarker for gastric tumor. Public Library of Science 2020-12-02 /pmc/articles/PMC7710035/ /pubmed/33264292 http://dx.doi.org/10.1371/journal.pone.0242145 Text en © 2020 Bu et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Bu, Jiyoon Lee, Tae Hee Jeong, Woo-jin Poellmann, Michael J. Mudd, Kara Eun, Hyuk Soo Liu, Elizabeth W. Hong, Seungpyo Hyun, Sung Hee Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
title | Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
title_full | Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
title_fullStr | Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
title_full_unstemmed | Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
title_short | Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
title_sort | enhanced detection of cell-free dna (cfdna) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710035/ https://www.ncbi.nlm.nih.gov/pubmed/33264292 http://dx.doi.org/10.1371/journal.pone.0242145 |
work_keys_str_mv | AT bujiyoon enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT leetaehee enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT jeongwoojin enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT poellmannmichaelj enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT muddkara enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT eunhyuksoo enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT liuelizabethw enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT hongseungpyo enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer AT hyunsunghee enhanceddetectionofcellfreednacfdnaenablesitsuseasareliablebiomarkerfordiagnosisandprognosisofgastriccancer |